APD:NYSEAir Products and Chemicals, Inc. Analysis
Data as of 2026-05-17 - not real-time
$295.38
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Air Products is trading at $295.38, comfortably above its 50‑day ($293.38) and 200‑day ($274.82) moving averages, with the 20‑day SMA ($300.24) providing a short‑term ceiling. The stock sits on a solid support around $291.52 and faces resistance near $307.96; while the RSI is neutral (46.7) and the MACD histogram is negative, the overall trend remains bullish.
Fundamentally, revenue grew 8.8% YoY to $12.46 B and margins are healthy (gross 32%, operating 24%). However, the balance sheet shows high leverage (debt‑to‑equity >100%) and negative free cash flow, raising questions about the sustainability of the 2.45% dividend (payout ~76%). Analysts are optimistic, maintaining a “Buy” consensus with a median price target of $330, implying ~10% upside, and recent earnings beat and hedge‑fund praise have reinforced short‑term momentum.
Fundamentally, revenue grew 8.8% YoY to $12.46 B and margins are healthy (gross 32%, operating 24%). However, the balance sheet shows high leverage (debt‑to‑equity >100%) and negative free cash flow, raising questions about the sustainability of the 2.45% dividend (payout ~76%). Analysts are optimistic, maintaining a “Buy” consensus with a median price target of $330, implying ~10% upside, and recent earnings beat and hedge‑fund praise have reinforced short‑term momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price hovering near technical support
- Bearish MACD signal
- High valuation relative to DCF
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median target of $330 (+10% upside)
- Q2 earnings beat and strong revenue growth
- Attractive dividend yield despite leverage
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term demand for industrial gases and hydrogen
- Elevated debt levels and negative free cash flow
- Stable cash flow from diversified global operations
Key Metrics & Analysis
Financial Health
Revenue Growth8.80%
Profit Margin16.91%
P/E Ratio31.2
ROE12.35%
ROA3.60%
Debt/Equity101.61
P/B Ratio4.2
Op. Cash Flow$4.1B
Free Cash Flow$-3519237376
Technical Analysis
TrendBullish
RSI46.7
Support$291.52
Resistance$307.96
MA 20$300.24
MA 50$293.38
MA 200$274.82
MACDBearish
VolumeStable
Fear & Greed Index88.52
Valuation
Fair Value$169.83
Target Price$327.86
Upside/Downside10.99%
GradeOvervalued
TypeBlend
Dividend Yield2.45%
Risk Assessment
Beta0.38
Volatility19.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.